Yingnan Li

671 total citations
34 papers, 460 citations indexed

About

Yingnan Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yingnan Li has authored 34 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Yingnan Li's work include Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (3 papers) and Hip disorders and treatments (3 papers). Yingnan Li is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (3 papers) and Hip disorders and treatments (3 papers). Yingnan Li collaborates with scholars based in China, Hong Kong and Switzerland. Yingnan Li's co-authors include Hongli Shan, Haihai Liang, Yingqi Liu, Xuelian Li, Yuhong Zhou, Lifang Lv, Lijia Zhang, Chaoqian Xu, Hua Jiang and Qihe Huang and has published in prestigious journals such as ACS Nano, Scientific Reports and IEEE Transactions on Industrial Electronics.

In The Last Decade

Yingnan Li

31 papers receiving 451 citations

Peers

Yingnan Li
Chandra S. Boosani United States
Melanie Katz United States
Lei Qi China
Guan‐Sheng Liu United States
Yingnan Li
Citations per year, relative to Yingnan Li Yingnan Li (= 1×) peers Weijie Dong

Countries citing papers authored by Yingnan Li

Since Specialization
Citations

This map shows the geographic impact of Yingnan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingnan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingnan Li more than expected).

Fields of papers citing papers by Yingnan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingnan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingnan Li. The network helps show where Yingnan Li may publish in the future.

Co-authorship network of co-authors of Yingnan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yingnan Li. A scholar is included among the top collaborators of Yingnan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingnan Li. Yingnan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yingnan, et al.. (2025). Scene-Adaptive Loader Trajectory Planning and Tracking Control. Sensors. 25(4). 1135–1135. 3 indexed citations
2.
Li, Yingnan, et al.. (2025). Novel Cascade Sliding Mode Control of Loader Electro-Hydraulic Systems Based on Improved Extended State Observers. IEEE Transactions on Industrial Electronics. 72(12). 14314–14324.
3.
Wang, Pan, Yansong Zhang, Yingnan Li, et al.. (2025). Using excitation-emission matrix-parallel factor analysis to access the effect of temperature parameters on the humification of community kitchen waste compost. Biomass and Bioenergy. 197. 107787–107787. 2 indexed citations
4.
Li, Yingnan, Yuming Zhang, Jifa Zhang, Zixuan Zhan, & Wuyu Mao. (2024). Development of novel focal adhesion kinase (FAK) inhibitors for targeting cancer: Structural insights and therapeutic potential. European Journal of Medicinal Chemistry. 279. 116913–116913. 4 indexed citations
5.
Zhao, Liang, Yaqi Liu, Yingnan Li, et al.. (2024). Modification of glycosyltransferase SrUGT76G1 based on computer-aided screening of mutation sites for efficient synthesis of rebaudioside M. Food Bioscience. 61. 104795–104795. 2 indexed citations
6.
Li, Zhihua, Man Huang, Yingnan Li, et al.. (2024). Emulsion‐Based Multi‐Phase Integrated Microbeads with Inner Multi‐Interface Structure Enable Dual‐Modal Imaging for Precision Endovascular Embolization. Advanced Healthcare Materials. 13(27). e2400281–e2400281. 7 indexed citations
7.
Yang, Rui, Liangliang Li, Yingnan Li, et al.. (2023). Long non-coding RNA KCND1 protects hearts from hypertrophy by targeting YBX1. Cell Death and Disease. 14(5). 344–344. 16 indexed citations
8.
Ma, Chenxi, et al.. (2023). Significance of m6A in subtype identification, immunological evolution, and therapeutic sensitivity of RA. Immunobiology. 229(1). 152781–152781. 2 indexed citations
9.
Sun, Jin, Yingnan Li, Mengjiao Shi, et al.. (2023). A Positive Feedback Loop of lncRNA HOXD-AS2 and SMYD3 Facilitates Hepatocellular Carcinoma Progression via the MEK/ERK Pathway. Journal of Hepatocellular Carcinoma. Volume 10. 1237–1256. 5 indexed citations
10.
Zhang, Anhang, Yingnan Li, Shouyuan Ma, et al.. (2022). Conicity-index predicts all-cause mortality in Chinese older people: a 10-year community follow-up. BMC Geriatrics. 22(1). 971–971. 23 indexed citations
11.
Gao, He, et al.. (2020). Fibula allograft propping as an effective treatment for early-stage osteonecrosis of the femoral head: a systematic review. Journal of Orthopaedic Surgery and Research. 15(1). 206–206. 9 indexed citations
12.
Li, Bing, et al.. (2020). Single approach to double-channel core decompression and bone grafting with structural bone support for treating osteonecrosis of the femoral head in different stages. Journal of Orthopaedic Surgery and Research. 15(1). 198–198. 8 indexed citations
13.
Lv, Lifang, Nan Zheng, Lijia Zhang, et al.. (2020). Metformin ameliorates cardiac conduction delay by regulating microRNA-1 in mice. European Journal of Pharmacology. 881. 173131–173131. 12 indexed citations
14.
Chen, Yingzhun, Xiaoguang Zhao, Jian Sun, et al.. (2019). YAP1/Twist promotes fibroblast activation and lung fibrosis that conferred by miR-15a loss in IPF. Cell Death and Differentiation. 26(9). 1832–1844. 71 indexed citations
15.
Zhao, Yanjie, Jian Zhang, Feng Shi, et al.. (2018). Expression of PD-1 on CD4+Tumor-Infiltrating Lymphocytes in Tumor Microenvironment Associated with Pathological Characteristics of Breast Cancer. Journal of Immunology Research. 2018. 1–8. 13 indexed citations
16.
Lv, Lifang, Tianyu Li, Xuelian Li, et al.. (2017). The lncRNA Plscr4 Controls Cardiac Hypertrophy by Regulating miR-214. Molecular Therapy — Nucleic Acids. 10. 387–397. 99 indexed citations
17.
Fu, Lu, Yingnan Li, Bin Yu, et al.. (2015). Norovirus P particle: An excellent vaccine platform for antibody production against Alzheimer’s disease. Immunology Letters. 168(1). 22–30. 17 indexed citations
18.
Wu, Hui, Haihong Zhang, Yue Hu, et al.. (2014). Sphere Formation Assay is not an Effective Method for Cancer Stem Cell Derivation and Characterization from the Caco-2 Colorectal Cell Line. Current Stem Cell Research & Therapy. 9(2). 82–88. 6 indexed citations
19.
Zhang, Wenhui, Changzheng Wang, Qing Chang, et al.. (2012). The Identification of miR-375 as a Potential Biomarker in Distal Gastric Adenocarcinoma. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 20(4). 139–147. 42 indexed citations
20.
Li, Yan, et al.. (2009). Present Status and Perspectives of Stem Cell-Based Therapies for Gastrointestinal Diseases. Stem Cell Reviews and Reports. 5(3). 278–282. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026